When was Scopio Labs founded?

Scopio Labs was founded in 2014 and raised its 1st funding round 3 years after it was founded.

Where is Scopio Labs located?

Scopio Labs is headquartered in Tel Aviv, Israel.

How many employees does Scopio Labs have?

As of Aug 31, 2026, the latest employee count at Scopio Labs is 153.

Is Scopio Labs a funded company?

Scopio Labs is a funded company, having raised a total of $125M across 7 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on May 24, 2017.

When was the latest funding round of Scopio Labs?

Scopio Labs' latest funding was a $***** Series D round on Jul 25, 2025, with participation from 1 investor.

Where does Scopio Labs rank among its competitors?

Scopio Labs ranks 9th amongst 291 active competitors, of which 80 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Techcyte, which secured $15M in Apr, 2026.

Who are the top competitors of Scopio Labs?

Scopio Labs' top competitors include PathAI, Deciphex and Aignostics. Among them, Techcyte secured the most recent funding round in April, 2026.

Scopio Labs - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of digital imaging platforms for hematology. The company uses computational photography to capture high-resolution (100X) full-field images of peripheral blood smears (PBS) and bone marrow aspirates (BMA), allowing labs to analyze entire slides without losing resolution or field of view.

Website: scopiolabs.com
Social
Email ID: *****@scopiolabs.com

Key Metrics

Founded Year

2014

Location

Tel Aviv, Israel

Stage

Series D

Total Funding

$125M in 7 rounds

Latest Funding Round

Series D, Jul 25, 2025, $*****

Investors

OurCrowd & 16 more

Ranked

9^th among 291 active competitors

Employee Count

153 as on Aug 31, 2026

Similar Companies

Aiforia & 215 more

View Scopio Labs' full profile

Scopio Labs has raised a total funding of $125M over 7 rounds. Its first funding round was on May 24, 2017. Its latest funding round was a Series D round on Jul 25, 2025 for $*****. 1 investor participated in its latest round. Scopio Labs has 15 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of Scopio Labs:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 25, 2025	3842695	Series D	4585575	5690063	9471244	3528457
Jul 25, 2024	8615682	Series D	9879423	7566320	5357294	2252158
Sep 28, 2022	8126189	Conventional Debt	4860328	4057516	9224069	Kreos Capital

Access funding benchmarks and valuations. Sign up today!

View details of Scopio Labs's funding rounds and investors

The founders of Scopio Labs are Itai Hayut and Erez Naaman.

Here are the details of Scopio Labs' key team members:

Itai Hayut: Co-Founder & CEO of Scopio Labs.
Contact Info: 1 email address
Erez Naaman: Co-Founder & CTO of Scopio Labs.

View details of Scopio Labs's Founder profiles and Board Members

Scopio Labs' employee count trend

Scopio Labs has 153 employees as of Aug 26. Here is Scopio Labs's employee count trend over the years:

Uncover Scopio Labs' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Scopio Labs include PathAI, Deciphex and Aignostics. Here is the list of Top 10 competitors of Scopio Labs, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	PathAI 2016, Boston (United States), Series C	Provider of digital pathology image management system for clinical labs	$255M	General Catalyst, Merck Global Health Innovation Fund ... & 22 others	71/100
2nd	Deciphex 2017, Dublin (Ireland), Series C	Network of pathologists providing digital diagnostic services for medical testing	$56.6M	Seroba Life Sciences, Molten Ventures & 13 others	65/100
3rd	Aignostics 2018, Berlin (Germany), Series B	Developer of artificial intelligence software for biomedical image analysis applications	$53.9M	Boehringer Ingelheim Venture Fund, Wellington Partners Venture Capital ... & 9 others	64/100
4th	Aiforia 2014, Helsinki (Finland), Public	Provider of an AI and cloud-based, deep learning image analysis platform in all therapy areas	$23M	Ascend Capital Partners, Businessfinland & 8 others	64/100
5th	Techcyte 2014, Orem (United States), Series B	Artificial intelligence (AI) based image analysis platform for pathologists	$50.4M	ARUP Laboratories, Zoetis & 2 others	61/100
6th	Nucle AI 2017, Chicago (United States), Series B	AI-assisted platform for image analysis	$60M	Vertex Ventures Israel, Sanofi Ventures & 9 others	61/100
7th	Morphle 2017, Bengaluru (India), Series A	Provider of robotic microtomes and digital pathology scanners. These devices automate tissue processing and slide scanning for anatomical pathology, dermatopathology, and hematology. The scanners offer high-resolution imaging and integrated workflows, facilitating efficient digital microscopy and telepathology applications. Various models cater to different throughput needs, from single-slide to high-volume batch processing. The company also offers AI-powered requisition data entry solutions.	$5.15M	Y Combinator, Inflexor & 4 others	61/100
8th	Visiopharm 2001, Horsholm (Denmark), Acquired	Developer of a SaaS and AI-based digital pathology solutions for image analysis and workflow standardization	$26.3M	BankInvest, Vaekstfonden & 4 others	60/100
9th	Scopio Labs 2014, Tel Aviv (Israel), Series D	Developer of digital imaging platforms for hematology	$125M	Kreos Capital, Viola Group & 15 others	46/100
10th	Deepcell 2017, Menlo Park (United States), Series C	AI-powered single cell classification and isolation technology for clinical research	$123M	Andreessen Horowitz, Bow Capital & 10 others	57/100